AnPac Bio-Medical Science Co. Ltd. (ANPC)
| Market Cap | 54.76M |
| Revenue (ttm) | 21.77M |
| Net Income (ttm) | n/a |
| Shares Out | 14.11M |
| EPS (ttm) | -1.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 30 |
| Last Price | $3.91 |
| Previous Close | $3.77 |
| Change ($) | 0.14 |
| Change (%) | 3.71% |
| Day's Open | 3.82 |
| Day's Range | 3.80 - 3.99 |
| Day's Volume | 61,806 |
| 52-Week Range | 3.15 - 12.09 |
Independent Director has Strong Track Record at US Fortune 500 Companies Independent Director has Strong Track Record at US Fortune 500 Companies
Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of ...
PHILADELPHIA, July 20, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has received its first disease treatment patent by the United States Patent and Trademark Office. The patent covers novel medical devices for both disease...
Are these biotech penny stocks to watch on your list for July 2021? The post Best Biotech Penny Stocks to Buy Next Month?
PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...
PHILADELPHIA, May 27, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United St...
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) will establish a joint venture with its founder and chairman, Dr. Chris Chang Yu, and certain other individuals to develop a new cancer treatment technolo...
SAN JOSE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (ANPC) (“AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United States...
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United St...
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Uni...
Earnings Call Scheduled for 8:30 am ET on April 30, 2021 Earnings Call Scheduled for 8:30 am ET on April 30, 2021
SAN JOSE, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Uni...
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), Surface Oncology, Inc. (NASDAQ: SURF) and CorMedix Inc. (NASDAQ: CRMD) are among the biggest movers among health care stocks Tuesday.
SAN JOSE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United Stat...
SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United Stat...
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United State...
Continues to Innovate and Build Strong IP Portfolio Continues to Innovate and Build Strong IP Portfolio
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific upd...
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United State...
SAN JOSE, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focuse...
AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC) shares were advancing strongly Wednesday after the company reported strong third-quarter testing volume and issued a strong full-year outlook. What...
AIM ImmunoTech (NYSE: AIM) shares are trading higher on Wednesday after the company dosed its first patient in a study evaluating ampligen as part of combination treatment for patients with cancer and C...
AnPac Bio (ANPC) news for Wednesday concerning performance during the company's third quarter of 2020 have ANPC stock on the rise. The post AnPac Bio News: Why ANPC Stock Is Skyrocketing 110% Today appe...
SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
SAN JOSE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
SAN JOSE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
SAN JOSE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
SAN JOSE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United State...
SAN JOSE, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Unit...
AnPac Bio-Medical Science Co., Ltd (ANPC) CEO Chris Yu on Q2 2020 Results - Earnings Call Transcript
AnPac Bio-Medical Science Co., Ltd (ANPC) CEO Chris Yu on Q2 2020 Results - Earnings Call Transcript
SAN JOSE, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the U...
Companies in the news are: IMAB, LMPX, DPW, ANPC
AnPac Bio-Medical Science (ANPC) saw an increase to ANPC stock on Friday following positive results from a clinical trial. The post Why AnPac Bio-Medical Science Stock Is Soaring 7% Today appeared first...
SAN JOSE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the U...
Earnings Call Scheduled for 8:00 am ET on September 10, 2020 Earnings Call Scheduled for 8:00 am ET on September 10, 2020
SAN JOSE, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
SAN JOSE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the Un...
The announcement that AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) has entered into a three-year strategic cancer screening collaboration contract with Beijing Yuan Jian Health Management in China ...
About ANPC
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
| Industry Biotechnology | IPO Date Jan 30, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol ANPC |
Financial Performance
In 2020, ANPC's revenue was 20.51 million, an increase of 89.11% compared to the previous year's 10.85 million. Losses were -80.48 million, -20.37% less than in 2019.
Analyst Forecasts
According to one analyst, the rating for ANPC stock is "Strong Buy" and the 12-month stock price forecast is 8.00.